Lotus Pharm vs OBI Pharma: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and OBI Pharma (4174) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ OBI Pharma

0%+306%-86%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYOBI PharmaYoY
Oct 2026NT$2.13 billion-22.5%NT$2.3 million-58.7%
Sep 2026NT$2.77 billion+128.0%NT$1.6 million-69.7%
Aug 2026NT$2.11 billion+81.7%NT$817,000-23.4%
Jul 2026NT$2.49 billion+3.9%NT$4.1 million-0.6%
Jun 2026NT$3.4 billion+225.5%NT$10.3 million+165.9%
May 2026NT$2.32 billion+105.8%NT$1.5 million-59.5%
Apr 2026NT$3.09 billion+19.9%NT$3.4 million-32.8%
Mar 2026NT$4.35 billion+173.6%NT$2.6 million-9.8%
Feb 2026NT$2.24 billion+131.5%NT$1.6 million-85.5%
Jan 2026NT$2.05 billion-5.5%NT$1.3 million+140.2%
Dec 2025NT$2.44 billion+66.9%NT$7.4 million-5.9%
Nov 2025NT$1.06 billion-0.2%NT$7.9 million+306.2%
Oct 2025NT$2.75 billion+46.0%NT$5.5 million+215.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16